Subcutaneous delivery of monoclonal antibodies: How do we get there?

Subcutaneous delivery of monoclonal antibodies presents several challenges during drug development process, such as drug formulation, immunogenicity, pharmacokinetic assessment during preclinical stage and translation into clinical practice.80